Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

AlphaLab Health Launches Fourth Cohort of Startups to Transform Patient Care


The cohort companies are:

  • D. Sole (d-sole.com) – D.Sole is a smart insole that utilizes multimodal sensors for the early detection and monitoring of foot complications, such as ulcers, in diabetic patients with neuropathy. The technology provides clinicians with critical data to proactively prevent severe ulcers and amputations, while also providing personalized care to diabetic patients.
  • Ilant Health (ilanthealth.com) – Ilant Health is an obesity treatment company, focused on increasing access to obesity treatment while reducing the total cost of care for employers and payers. The company provides the single front door for individuals with obesity, delivering end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice.
  • Magnify Bioscience (magnifybiosci.com)– Magnify Biosciences Inc. empowers its customers by removing the traditional barriers to high-end nanoscale imaging. Their innovative Tissue Magnification technology enhances customers’ microscopes to accelerate biological discovery, offering profound insights that catalyze breakthroughs in both fundamental research and clinical applications.
  • MetasTx (metastx.com) – MetasTx, LLC is developing novel diagnostics and therapeutics to treat and prevent metastatic cancer beginning with prostate cancer (PCa). The MetasTx platform is focused on PAK1, a target that has been demonstrated to be crucial for cancer cell initiation, proliferation, and metastasis. MetasTx is designing and developing novel chemicals to create a breakthrough, First-In-Class PAK1 inhibitor that will significantly improve patient survival and quality of life.
  • Resilient LifeScience (http://www.resilient.bio) – Opioid overdose is the leading killer of Americans under 50, and roughly 80% of the 80,000 annual overdose deaths occur without a bystander to administer lifesaving naloxone. Resilient LifeScience is developing a wearable medical device to automatically detect and reverse an opioid overdose.
  • Testa-Seat (testa-seat.com) – Testa-Seat is revolutionizing the manufacturing process of products for individuals with disabilities to create life-changing custom products in a sustainable and environmentally friendly way.

“The companies that have gone through the AlphaLab Health accelerator have been confronting and proposing solutions to some of medicine’s most complicated issues including addressing difficult issues regarding specific diseases, how social determinants of health impact patient’s response to disease, how hospitals operate and care for patients,” said Dr. Jeff Cohen, chief physician executive, community health and innovation for AHN. “Each company targets a unique problem and collaborates with AHN and Highmark staff affected by the problem. All the participants are striving to improve the future delivery of healthcare. This new cohort continues in this innovative vein, and we look forward to seeing how AlphaLab Health amplifies their outcomes.”

Each company in the fourth cohort will receive up to $100,000 in pre-seed investment, wet and dry lab space, one-on-one and group education sessions, and access to clinicians, hospital executives and other experts who can help these emerging companies succeed through the early stages of development.

“AlphaLab Health is central to our ongoing commitment to supporting life sciences companies in Southwest PA,” said Ven Raju, president and CEO of IW.

Ven continued, “AlphaLab Health supports life sciences companies with capital, deep domain expertise in conjunction with our partnership with Highmark-AHN and state-of-the-art facilities including wet lab space. The programming is designed to shepherd companies through the early stages of the business and development life cycle and provide companies with access to key networks such as investors, customers and mentors. The unique partnership between Highmark AHN and IW bring to bear the resources and know-how of a large integrated health system with that of a leading venture development organization to help early stage life sciences companies in the region. We are excited to welcome our 4th cohort of companies to the program.”

To learn more about AlphaLab Health, visit https://www.alphalabhealth.org/.

About the Allegheny Health Network:
Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 22,000 people, has more than 2,600 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

About AlphaLab Health
AlphaLab Health (http://www.alphalabhealth.org) is a program of Innovation Works (IW) in partnership with Allegheny Health Network (AHN). IW and AHN bring their resources and expertise together to deliver greater value to health and life science related companies in the Pittsburgh region, nurturing innovations that will change health care and create growth for the regional economy. AlphaLab Health gives entrepreneurs access to specialized clinicians, insurers, hospital administrators and domain experts that accelerate the new company’s growth. The program links emerging companies with early customers, corporate partners, potential investors and knowledgeable staff and mentors so entrepreneurs can bring to life the innovations that will change and improve patient care.

About Innovation Works
Innovation Works (IW) is the region’s most active pre- and seed-stage investor and one of the most active early-stage investors across the country. Since 1999, IW has invested more than $24 million in life sciences companies and our life sciences portfolio has raised over $1.3 Billion in follow-on funding. In addition to providing investment through the only seed fund exclusively focused on the greater Pittsburgh region, Innovation Works has numerous programs and accelerators to advance high-potential startups in every type of technology: software, hardware, and life sciences. IW’s renowned AlphaLab accelerators (AlphaLab, AlphaLab Gear, and AlphaLab Heath) adapt to entrepreneurs’ time frames and educational needs with flexible start times, tailored programming, and entrepreneurially friendly investment terms. IW is the Southwestern PA Ben Franklin Technology Partner, a network of four statewide centers to advance innovation in Pennsylvania and partially funded through and overseen by the commonwealth’s Department of Community and Economic Development. For more information, go to https://www.innovationworks.org/.

Media Contact

Emily Beatty, Allegheny Health Network, 5136789620, [email protected], www.ahn.org

SOURCE Allegheny Health Network

Study Shows Providers Experience Lower Medical Malpractice Losses With MagMutual Risk Mitigation Advice


The analysis included data from 35,796 unique providers with Physician and Surgeon Liability policies effective from 1998-2022 and covered all specialties. The segments included two groups: providers who have taken courses focused on risk mitigation or used one of MagMutual’s risk mitigation tools and providers who have done neither.

“In always putting our policyholders first, it’s important that we help them understand and mitigate their risk better than any other insurer could. The results show that our policyholders are applying the evidence-based strategies developed by our medical faculty, experiencing even better patient outcomes and seeing a tangible reduction in claims,” said Mark Poling, chief customer officer, MagMutual.

MagMutual’s Learning Center includes more than 300 different resources focused on various subject matters, specialties and products. MagMutual continues creating evidence-based content for policyholders to reduce risk even further.

About MagMutual
For more than four decades, MagMutual has been a leading provider of medical professional liability insurance. Today, we’re the largest mutual insurer of physicians and the second largest mutual medical professional liability carrier in the U.S.*, delivering comprehensive coverage to more than 40,000 healthcare providers and organizations nationwide. Our focus on innovation allows us to offer customized advice, exceptional claims support and consistent financial benefits that result in improved outcomes and stronger PolicyOwners.

*Market position based on S&P Global Market Intelligence 2022 year-end financial filings. Dividends and other policyholder benefits are declared at the discretion of the MagMutual Board of Directors and are subject to eligibility requirements.

Media Contact
Kristen Guilfoil, MagMutual, 404-842-3460, [email protected], www.magmutual.com

Twitter

SOURCE MagMutual



Allegheny Health Network Program for Older Adults Receives Top Designation from American Geriatrics Society


Designed to enhance care for older adults during a hospital stay, the Allegheny Health Network (AHN) Division of Geriatrics’ Hospital Elder Life Program (HELP) is among a small number of programs nationwide that have received the ‘Center of Excellence’ designation

PITTSBURGH, Dec. 7, 2023 /PRNewswire-PRWeb/ — Allegheny Health Network’s (AHN) Division of Geriatrics, part of the AHN Primary Care Institute, and the AHN Nursing Institute announced today that its Hospital Elder Life Program (HELP) has been awarded ‘Center of Excellence’ (COE) status by the American Geriatrics Society (AGS). AHN is one of just seven sites nationally to achieve the COE designation, out of approximately 200 programs implemented across the country and around the world.

The esteemed designation was awarded following AHN’s demonstration of a longstanding commitment to the AGS care model, formally known as ‘CoCare®: HELP,’ and for sustaining and expanding the program across AHN. The program was first implemented at AHN’s West Penn Hospital before expanding to Allegheny General Hospital (AGH).

According to AGS, HELP is a well-studied, effective and innovative model of hospital care designed to prevent both delirium and functional decline among older patients. The program is intended to integrate the principles of geriatrics into standard nursing and medical care on any hospital unit, and to bring geriatric expertise to bear on patient care decisions. Among the program’s benefits, it has been demonstrated to improve patient outcomes and satisfaction of care, lower costs of care, reduce hospital readmissions, and more.

Supported by an AHN multidisciplinary care team, onsite elder nurse life specialists work alongside specially trained hospital volunteers at AGH and West Penn to provide targeted interventions and address a broad scope of geriatric issues known to contribute to cognitive and functional decline during hospitalization. This can include cognitive orientation and stimulation activities, therapeutic activities, sleep enhancement strategies, exercise and mobilization, hearing and vision aids, feeding assistance and dehydration prevention, family support and education and individualized discharge planning.

“This status recognizes our adherence to national program standards, honors our achievement of favorable patient outcomes, and provides AHN the opportunity to serve as an educational site for acute geriatric care,” said Lyn Weinberg, MD, geriatrician and director of the Division of Geriatrics at AHN. “We are extremely grateful to the American Geriatrics Society for recognizing our program in this special way and appreciate their continued partnership in the care of older adults at AHN.”

Dr. Weinberg says that with the successful implementation and sustainment of HELP at West Penn and AGH, the division intends to gradually expand the program to other AHN hospitals.

To learn more about geriatric health care services at AHN, visit http://www.ahn.org/primary-care/geriatrics.

About Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

About the American Geriatrics Society
Founded in 1942, the American Geriatrics Society (AGS) is a nationwide, not-for-profit society of geriatrics healthcare professionals dedicated to improving the health, independence, and quality of life of older people. Its 6,000+ members include geriatricians, geriatrics nurse practitioners, social workers, family practitioners, physician assistants, pharmacists, and internists who are pioneers in serious-illness care for older individuals, with a focus on championing interprofessional teams, eliciting personal care goals, and treating older people as whole persons. For more information, visit AmericanGeriatrics.org.

Media Contact

Candace Herrington, Allegheny Health Network, 412-951-8193, [email protected], www.ahn.org

SOURCE Allegheny Health Network

SAFE Credit Union Hosts Interactive Financial Literacy Workshops


“I think it’s a wonderful opportunity for students to come learn how to manage their finances, what they should be doing to prepare for the real world while in college and set themselves up for success after they graduate,” says Sasha Margulies, ASI marketing coordinator.

Budget Cents is a simulation where each participant receives a persona that includes a family, debt, and income. They visit various stations representing major expenses, including childcare, housing and transportation costs.

At Sacramento State, SAFE representatives helped students with their budget and provided feedback to see how they successfully managed their money.

The event attracted participants from diverse backgrounds through outreach from the university’s ASI program. ASI offers services including a food pantry, childcare, a safe ride program and no-cost education events.

Students like Lorena Rodriguez appreciated the program’s insights. “The information to pay extra on the amount due to your credit card was very helpful,” she says. “I did not know that before.”

SAFE Credit Union Financial Wellness Manager Hector Madueno says students attending Budget Cents are most surprised “by how much things cost.”

“When we built this program, we looked at data for the Greater Sacramento area. So, when they are running through it, they’re going to see actual housing costs, the actual costs of food or dining out,” he says.

Budget Cents programs are offered at no-cost.

“A lack of financial education can lead to young adults making mistakes that can impact them for years,” says SAFE Credit Union Vice President of Community Relations and Financial Education Rebecca Delmundo. “Helping young people learn positive spending and budgeting practices can position them for a better future, especially when it comes time for those major life milestones like buying a house, new car, or starting a family.”

About SAFE

SAFE Credit Union is a not-for-profit, state-chartered credit union in Northern California with over $4.7 billion in assets and more than 236,000 members. Insured by NCUA.

Media Contact

Robyn Eifertsen, SAFE Credit Union, 916-809-7002, [email protected], safecu.org

SOURCE SAFE Credit Union

Prominent Dallas Facial Plastic Surgeon, Dr. Stefan Shuaib, is Recognized as a 2023 Top Patient Rated Dallas Doctor by Find Local Doctors



Dr. Stefan Shuaib, a double board certified and renowned expert in his field, is one of Dallas, TX’s most respected facial plastic surgeons and is widely known for delivering incredible outcomes.

IRVING, Texas, Dec. 7, 2023 /PRNewswire-PRWeb/ — Dr. Stefan Shuaib has earned this distinguished award from Find Local Doctors as a result of his five-star ratings and exceptional patient reviews. Find Local Doctors is a user-friendly online directory, that helps consumers connect with skilled physicians in their area who are well-known for their expertise. Facial aesthetics are important for confidence and self-esteem, and in Dallas, TX, patients can depend on Dr. Shuaib and his team at Dallas Facial Plastic Surgery Center to achieve natural, stunning aesthetic results. Some of the procedures offered for women and men at the state-of-the-art practice include rhinoplasty, facelift surgery, neck lift, cosmetic ear surgery, blepharoplasty, facial reconstruction and chin implants. Known as a perfectionist when it comes to performing facial cosmetic procedures, Dr. Shuaib employs the most cutting-edge and innovative surgical techniques available. With his meticulous approach and artistic eye, Dr. Shuaib has earned a reputation as a top-rated surgeon in the field of facial aesthetics. His patients rave about his ability to enhance their natural beauty while maintaining a refreshed and youthful appearance.

Uptiv Health Unveils Its Patient-Centric App For Enhanced Infusion Therapy Experience


Uptiv Health’s Innovative Digital Platform Elevates Patient Care with Personalized Features and Real-Time Communication

DETROIT, Dec. 7, 2023 /PRNewswire-PRWeb/ — Recently recognized by Galen Growth as one of HealthTech’s 250 most promising early-stage digital health ventures in 2023, Uptiv Health, a leader in whole-person infusion care, has introduced an innovative patient engagement application. It includes features designed to empower the patient and extend the care provided by Uptiv beyond the four walls of an infusion center.

Since its August 2023 launch, Uptiv Health has experienced consistent growth in patients receiving infusion therapy at their Westland, MI location. The complimentary patient app has received widespread acclaim and adoption, consistently earning 5-star reviews on Google and app stores. Patients praise the comfortable clinic setting, caring staff, personalized experience, easy onboarding, and user-friendly app.

“Our vision at Uptiv Health has always been to place patients at the heart of everything we do, and our app is a crucial step in realizing this vision,” said Torben Nielsen, CEO of Uptiv Health. “By integrating technology with patient-centered care, we’re not just enhancing the infusion therapy experience, we’re transforming the entire healthcare journey into a more human, personalized, and accessible one. This app embodies our commitment to empowering patients with the tools and support they need for better health outcomes.”

Uptiv Health’s app, accessible via iOS, Android, and web, introduces key innovative features for a holistic patient experience:

  • Real-Time Communication: Patients can easily communicate with the clinical team through the app for quick responses via secure chat and video sessions.
  • Appointment Management: Timely reminders assist patients in staying on track with their infusion therapy schedule, reducing cancellations and no-shows.
  • Digital Check-In and Onboarding: Patients can digitally check in from home, sign consent forms, fill out onboarding forms, and access important documents.
  • Personalized Infusion Preferences: Patients can customize their infusion experience, specifying preferences such as room temperature, entertainment options, and drink and snack choices, and notify the care team if they’re bringing a guest.
  • Access to medical history: Patients can see their medical history, inclusive of medications, allergies, infusion notes, and care summaries.
  • Community and Care Circles: Fostering unified care and collaboration, patients can add caregivers to their profile, ensuring everyone is informed and involved.
  • Care Planning and Coordination: The care team can set care goals with patients, assess their needs, and work toward those goals through tailored activities.
  • Transparent Billing and In-App Payment: Patients can view co-pay amounts and make payments directly through the app, simplifying the financial aspects of their care.

Marina Simonian, Head of Product for Uptiv Health, noted strong patient app engagement, with 100% of patients having utilized the app to complete their onboarding paperwork, sign consent forms, and share their infusion preferences with the care team.

“Multiple patients have also used it to pay their copays or message with the team to change an appointment date or ask a question,” said Simonian. “We’re very encouraged by this high adoption rate as it reflects the growing demand for consumer-grade digital solutions in healthcare settings, as well as the readiness of patients to embrace such technologies.”

In conclusion, as healthcare continues to embrace digital transformation, Uptiv Health’s app stands out through its patient-centric design and seamless integration with the in-person treatment experience. It exemplifies how technology can enhance patient care, ensuring a hassle-free, transparent, and empowering journey toward better health.

Uptiv Health invites patients and healthcare professionals to join them as the company continues to innovate and transform the infusion industry. Learn more about Uptiv Health at https://www.uptivhealth.com/ and follow on LinkedIn, Facebook, and Instagram.

About Uptiv Health

Uptiv Health redefines infusion therapy for patients suffering from chronic conditions. Providing a hybrid experience with comfortable, highly personalized in-person care and a consumer-friendly digital platform, Uptiv Health ensures patients’ overall well-being. The platform simplifies onboarding, communication, appointments, payments, and symptom monitoring. Uptiv Health accepts Medicare, is in-network with most health insurance plans in Michigan, and provides transparent upfront pricing at a substantially lower cost than traditional hospital infusion treatment centers.

Media Contact

Marina Simonian, Uptiv Health, 1 7342030176, [email protected], https://www.uptivhealth.com/

LinkedIn

SOURCE Uptiv Health

Rimidi Achieves HITRUST Essentials 1-year (e1) Certification, Demonstrating Foundational Cybersecurity Measures


“As a leading digital health platform working with protected health information, the importance of ensuring patient data remains secure cannot be understated,” said Jennifer Ide, J.D., Chief Legal and Compliance Officer of Rimidi. “Through the HITRUST e1 Certification, we are further illustrating our dedication to protecting sensitive customer data within the Rimidi platform.”

The company also recently attained the provisional certification status for TX-RAMP, allowing Texas healthcare organizations to utilize Rimidi’s secure, leading digital health platform within their existing EHR workflows.

“The HITRUST e1 Validated Assessment is a good tool for cyber-aware organizations to build assurances and progressively demonstrate due diligence around information security and privacy,” said Robert Booker, Chief Strategy Officer, HITRUST. “We applaud Rimidi for their commitment to cybersecurity and successful completion of their HITRUST e1 Certification.”

To learn more about Rimidi’s secure cloud-based software solutions for remote patient monitoring and chronic disease management, visit rimidi.com/solutions.

About Rimidi
Created by doctors, for doctors, Rimidi is a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. By combining clinical data from the EHR with data from connected devices and patient surveys, Rimidi presents a complete picture of the patient and supports care delivery across the continuum from the clinic to the home to allow for proactive, guideline-based management and prioritization of highest-need patients. For more information, visit rimidi.com and follow us on X, formerly known as Twitter, and LinkedIn

Media Contact

Michelle Rand, Alloy, on behalf of Rimidi, 855.300.8209, [email protected], https://rimidi.com/

SOURCE Rimidi



Feel Therapeutics Announces Study Results of their Proprietary Digital Precision Medicine Platform, Validating Promising Impact on Mental Health Conditions


Feel is leading the way by bringing precision medicine to mental health, starting with the collection of continuous passive and objective data from their proprietary Digital Precision Medicine Platform. Through this platform, Feel translates complex and heterogeneous data to generate a 360-degree view of a patient’s mental health. This information serves as a foundation for real-time, personalized support and interventions 24/7/365.

“Our vision is a world where precision medicine advances the treatment of mental health, enabling proactive and personalized interventions and, ultimately, empowering individuals to live healthier, happier lives,” said George Eleftheriou, CEO and co-founder of Feel Therapeutics. “The momentum in this field is undeniable, and by leveraging digital and physiological data from wearables and our mobile phones, we have an incredible opportunity to support individuals in the real world in a personalized way. Whether digital or pharmaceutical interventions, the goal is delivering the right treatment to the right patient at the right time, transforming the management and outcomes in mental health.”

Feel Therapeutics, building on the success of their previous study, has demonstrated that their Digital Precision Medicine Platform not only improves outcomes in depression and anxiety (MDD/GAD) but also extends its benefits to address chronic conditions. A recently released feasibility and usability study reaffirms the platform’s value for adults exhibiting ADHD symptomatology while dealing with coexisting depressive or anxiety symptoms – a common use case for the Feel platform.

“Mental and behavioral health is long overdue for its precision medicine revolution,” said Haris Tsirmpas, Co-Founder and CTO of Feel Therapeutics. “In the past, the field leaned heavily on self-reported questionnaires due to a lack of objective measurements. Now, with data collected from wearable devices and mobile sensors, but also voice, video, text, and passive behavioral data, we can extract digital phenotypes and insights. This data paves the way for personalizing treatments, bringing the field closer to the vision of precision medicine. Our goal remains clear: to provide everyone with access to the right diagnoses and care based on reliable, objective data.”

Feel has partnerships with four of the largest pharma and life science companies to generate evidence in clinical and real-world studies, as well as to improve adherence and patient outcomes alongside medications.

To learn more, please visit: http://www.feeltherapeutics.com

About Feel Therapeutics:
Feel Therapeutics is a Digital Precision Medicine company bringing objective and passive monitoring to reinvent the way we diagnose, manage, and care for mental & behavioral health.

The company is backed by top-tier investors and partners with Pharmaceutical companies and CROs to generate evidence and bring precision Drug+ and DTx solutions to market as standalone or alongside medications.

Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe.

Media Contact

Cameron Gordon, JDI, 410-504-9380, [email protected]

SOURCE Feel Therapeutics

Alcatraz AI Unveils Key Biometric Access Control Trends for 2024


Alcatraz AI Unveils Key Biometric Access Control Trends for 2024

CUPERTINO, Calif., Dec. 7, 2023 /PRNewswire-PRWeb/ — Alcatraz AI, a global leader in frictionless access control solutions, announces the latest trends to shape the biometric access control landscape in 2024. As the industry continues to evolve, Alcatraz AI remains at the forefront, ushering in innovations prioritizing ethics, sustainability, data privacy, and ease of implementation.

“Biometrics for access control are poised for a transformative era, propelled by the evolving landscape of access control technology, heightened safeguards for individual privacy, and the escalating need for streamlined solutions,” said Tina D’Agostin, CEO of Alcatraz AI. “Our commitment lies in creating access control technology that not only embraces these shifts but also paves the way for future-proof technology, ensuring uncompromising security and frictionless experiences.”

Biometric Access Trends for 2024:

  • Ethical AI: Ethical considerations take center stage as AI integrates into access control. Ensuring fairness and transparency is paramount.
  • Sustainable Technology: Biometric access control embraces sustainability through energy efficiency, eco-materials, and renewable energy, addressing environmental concerns.
  • Data Privacy & Compliance: Stricter data privacy regulations require robust security standards. Transparency and user control over data collection and usage are essential.
  • Open Standard: Access control systems shift to easy-to-implement and scale solutions. Plug-and-play designs simplify adoption, and scalability becomes cost-effective.

Download the 2024 Trends in Biometric Access Control eBook to Learn More: https://alcatraz.ai/resources/2024-access-control-trends-0

About Alcatraz AI 
Founded in 2016, Alcatraz AI uses AI and machine learning to deliver industry-leading facial authentication solutions to all access control systems to more effectively and efficiently keep people and spaces safe and secure. With its patented technology, Alcatraz AI’s facial authentication solution, intelligent tailgating detection, and simplified enrollment process work natively with existing access control systems to transform physical security and protect individual privacy. With a vision of simplicity, security, and privacy, Alcatraz AI is trusted to protect more than one million employees at Fortune 500 companies.

For more information, please visit http://www.alcatraz.ai and follow @alcatrazai on X and Alcatraz on LinkedIn.

Media Contact

Linda Ebrahimian, Alcatraz AI, 8186368787, Linda@alcatraz.ai

SOURCE Alcatraz AI

Corista Announces Partnership with AGFA HealthCare to Enhance Digital Pathology Integration in Healthcare


Elizabeth Wingard, CEO and Co-founder of Corista, comments on the partnership: “Our collaboration with AGFA HealthCare is a testament to our shared commitment to healthcare excellence. Corista’s experience with top academic institutions complements AGFA’s vision for enterprise medical imaging, creating a seamless care continuum that extends the benefits of AI and digital integration directly to patient care.”

Dr. Anjum Ahmed, Chief Medical Officer at AGFA HealthCare, adds: “By integrating Corista’s DP3® technology into our Enterprise Imaging Platform, we’re empowering pathologists with advanced tools to enhance diagnostic confidence and efficiency. Our goal is to streamline the complex pathology workflow, so that patients receive the benefit of rapid, precise, and integrated healthcare delivery.”

Corista has been at the forefront of developing digital pathology solutions, and its collaboration with AGFA HealthCare marks a crucial step in broadening the scope of integrated healthcare. This partnership facilitates enhanced collaboration among different medical specialties, leading to more streamlined and precise patient care.

Corista DP3® is certified for diagnostic use under CE-IVDR.

*1 Enterprise Imaging for Pathology is available in UK and Europe only

About Corista

Corista is recognized for its innovations in digital pathology, providing solutions that enhance diagnostic and operational efficiency. The company’s DP3® platform equips pathologists with essential tools for managing diagnostic workflows and facilitating consultations within and between healthcare organizations.

About AGFA HealthCare

At AGFA HealthCare, we are transforming the delivery of care – supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates – channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group.

For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.

AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.

For more information about Corista and AGFA HealthCare, please visit www.corista.com and www.agfahealthcare.com.

Legal Notice:

Copyright 2023 Corista, LLC. All rights reserved. AGFA and the AGFA rhombus are registered trademarks of AGFA-Gevaert N.V. Belgium or its affiliates. DP3 is a registered trademark of Corista, LLC.

Media Contact

Anne Marsden, Marsden Marketing, 1 678.369.0073, [email protected]

SOURCE Corista